Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Choosing zero based budgeting can significantly improve your financial awareness. Discover the reasons to adopt this method today.
22,367 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
A new Redfin analysis using Federal Reserve data shows Americans aged 70-plus now hold a 26% share of U.S. real estat...
Tempo, the stripe-backed crypto startup, launches a cross-chain AI payments protocol and goes live with its Tempo blo...
Ecopetrol sits at the intersection of commodity pricing, currency risk, and refining margins. This guide breaks down ...
Evernorth moves to go public through a SPAC merger, aiming to convert XRP exposure into a participatory, yield-genera...
Investors chase $100,000 a year in dividend income, but the required capital hinges on yield and payout durability in...
In 2026, unicorns flush with cash face a new bottleneck: cap table gridlock. Despite record funding, ownership comple...
CBS News confirmed it will shut down its CBS News Radio service by May 22, 2026, a move that ends a nearly 100-year e...
Alibaba heads into 2026 with two clear catalysts. This analysis lays out the two big predictions, explains why they c...
Palantir Technologies is at a crossroads as AI-driven data analytics demand tightens. This long-range look maps 2026-...
Wall Street predicts these three AI stocks could double within four years as demand for AI infrastructure and memory ...
Target's Circle Deal Days is more than a promo. It could be a lever for traffic, online sales, and margins. This arti...